Company Filing History:
11 out of 35 
2 out of 17,173 
2 out of 39 
Years Active: 2009-2019
Title: Cynthia Monesa Clark: Innovator in Protein Tyrosine Phosphatase Inhibitors
Introduction
Cynthia Monesa Clark is a prominent inventor based in Concord, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of human protein tyrosine phosphatase inhibitors. With a total of 16 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
Among her latest patents, Cynthia has focused on compounds that act as human protein tyrosine phosphatase beta (HPTP-β) inhibitors. These compounds are crucial for regulating angiogenesis, which is the formation of new blood vessels. The patents detail compositions that include these inhibitors and methods for their use in regulating angiogenesis, showcasing her innovative approach to addressing complex biological processes.
Career Highlights
Cynthia has worked with notable companies such as Aerpio Therapeutics, Inc. and The Procter & Gamble Company. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Cynthia has collaborated with esteemed colleagues, including Jeffrey Lyle Gray and Kande K D Amarasinghe. These partnerships have further enhanced her research and development efforts, leading to advancements in her area of expertise.
Conclusion
Cynthia Monesa Clark stands out as a leading inventor in the realm of protein tyrosine phosphatase inhibitors. Her innovative work and collaborations continue to pave the way for advancements in medical science.